［1］Siegel R，Naishadham D，Jemal A.Cancer statistics［J］.CA Cancer J Clin，2013，63(1)：11-30.
［2］Enneking WF，Spanier SS，Goodman MA.A system for the surgical staging of musculoskelet al sarcoma［J］.Clin Orthop Relat Res，2003(415)：4-18.
［3］Qi WX，He AN，Tang LN，et al.Evaluation of pirarubicincisplatin chemotherapy in the treatment for refractory and recurrent highgrade osteosarcoma：experience of a single institute［J］.Med Oncol，2012，29(3)：2229-2233.
［4］Veth R，van Hoesei R，Pruszczynski M，et al.Limb salvage in musculoskelet al oncology［J］.Lancet Oncol，2003，4(6)：343-350.
［5］Enneking W.Musculoskelet al Tumor Surgery［M］.New York：ChurchillLivingstone，1983：3-27.
［6］Noria S，Davis A，Kandel R，et al.Residual disease following unplanned excision of softtissue sarcoma of an extremity［J］.J Bone joint Surg(Am)，1996，78(5)：650-655.
［7］Ekardt JJ，Kabo JM，Kelley CM，et a1.Expandable endoprosthesis reconstruction in Skelet ally immature patients with tumors［J］.Clin Orthop Relat Res，2000(373)：5l-61.
［8］San-Julian M，Aquerreta JD，Benito A，et al.Indications for epiphyseal preservation in metaphyseal malignant bone tumors of children：relationship between image methods and histologocal findings［J］.J Pediatr Orthop，1999，19(4)：543-548.
［9］鲁大路，李斌，杨大兴，等.新辅助化疗联合保肢术治疗合并病理性骨折骨肉瘤的临床观察［J］.实用癌症杂志，2014，29(7)：879-882.
［10］Jiang F，Shi Y，Li GJ，et a1.A meta-analysis of limb-salvage versus amputation in the treatment of patients with Enneking double daggerU pathologic fracture osteosarcoma［J］.Indian J Cancer，2015，51(Supp12)：e21-24.
［11］刘彧，刘水涛，扈文海，等.伴病理性骨折的原发恶性骨肿瘤保肢手术疗效评价［J］.临床外科杂志，2016，24(1)：65-67.
［12］Meyem PA，Schwartz CL，Krailo M，et a1.Osteosarcoma：a randomized，prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin，doxorubicin，and high dose methotrexate［J］.J Qlin Oncol，2005，23(9)：2004-2011.
［13］Krieg AH，Hefti F.Reconstruction with nonvascularised fibular grafts after resection of bone tumours［J］.J Bone Joint Surg (Br)，2007，89(2)：215-221.
晋公网安备 14010702070875号